TABLE 3.

Median overall survival in patients with bladder carcinoma and variant histology within the SEER from 2004 to 2015.

	Median OS (95% CI), mo a
Histologic type	PLND	No PLND
Transitional cell carcinoma	52.00 (49.04–54.96)	39.00 (34.79–43.21)
Squamous cell carcinoma	24.00 (16.04–31.96)	14.00 (9.19–18.81)
Adenocarcinoma	36.00 (22.32–49.68)	38.00 (14.46–61.54)
Small cell carcinoma	22.00 (15.35–28.65)	15.00 (0.59–29.41)
Neuroendocrine carcinoma	33.00 (1.61–64.39)	/
Signet ring cell carcinoma	18.00 (12.62–23.38)	13.00 (5.67–20.33)
Pseudosarcomatous carcinoma	8.00 (2.94–13.06)	89.00 (0.00–214.89)
Other histology	38.00 (16.16–59.84)	22.00 (2.49–41.51)
Overall	49.00 (46.27–51.73)	37.00 (33.13–40.87)

95% CI, 95% confidence interval; OS, overall survival; PLND, pelvic lymph node dissection.